Axsome Therapeutics Inc stock is traded at $129.80, with a volume of 1,109,526. It is down -5.26% in the last 24 hours and down -25.55% over the past month. Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
Previous Close:
$137.00
Open:
$137.00
24h Volume:
1,109,526
Relative Volume:
0.80
Market Cap:
$6.83B
Revenue:
$708.24M
Net Income/Loss:
-$188.30M
P/E Ratio:
-
EPS:
-$3.74
Net Cash Flow:
-$70.99M
1W Performance:
-10.13%
1M Performance:
-25.55%
6M Performance:
-41.70%
1Y Performance:
-6.89%
1-Day Range:
$0.00$0.00
1-Week Range:
$123.00$145.50
52-Week Range:
$123.00$260.19
Axsome Therapeutics Inc Stock (AXSM) Company Profile
Name
Axsome Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
(212) 332-3241Address
ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS